An emergency department intervention to increase warfarin use for atrial fibrillation

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 2, 2014, Pages 199-203

  Skolarus, Lesli E ^a   Morgenstern, Lewis B ^a,b   Scott, Phillip A ^a,b   Lisabeth, Lynda D ^a   Murphy, Jillian B ^a   Migda, Erin M ^a   Brown, Devin L ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Atrial fibrillation; emergency department; health services research; stroke prevention

Indexed keywords

WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; TOTAL QUALITY MANAGEMENT;

ATRIAL FIBRILLATION; EMERGENCY DEPARTMENT; HEALTH SERVICES RESEARCH; STROKE PREVENTION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; DRUG UTILIZATION REVIEW; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY PREVENTION; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; STROKE; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 84893402366     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2012.11.005     Document Type: Article

References (13)

1. A.P. Wilper, S. Woolhandler, and K.E. Lasser et al. Waits to see an emergency department physician: U.S. trends and predictors, 1997-2004 Health Affairs 27 2008 W84 W95
2. W.M. Feinberg, J.L. Blackshear, and A. Laupacis et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications Arch Intern Med 155 1995 469 473
3. A.S. Go, E.M. Hylek, and K.A. Phillips et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
4. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
5. G.W. Albers, J.M. Yim, and K.M. Belew et al. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals Arch Intern Med 156 1996 2311 2316
6. P.A. Scott, A.M. Pancioli, and L.A. Davis et al. Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients Stroke 33 2002 2664 2669
7. P. Laguna, A. Martn, and C. del Arco et al. Risk factors for stroke and thromboprophylaxis in atrial fibrillation: What happens in daily clinical practice? The GEFAUR-1 study Ann Emerg Med 44 2004 3 11
8. B.F. Gage, A.D. Waterman, and W. Shannon et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
9. R.A. Elliott, M.C. Woodward, and C.A. Oborne Antithrombotic prescribing in atrial fibrillation: Application of a prescribing indicator and multidisciplinary feedback to improve prescribing Age Ageing 31 2002 391 396
10. B.V. Bajorek, I. Krass, and S.J. Ogle et al. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A pharmacist-led multidisciplinary intervention J Am Geriatr Soc 53 2005 1912 1920
11. T.R. Frieden, and D.M. Berwick The "Million Hearts" initiative - Preventing heart attacks and strokes N Engl J Med 365 2011 e27
12. J.M. Stern, and R.J. Simes Publication bias: Evidence of delayed publication in a cohort study of clinical research projects BMJ 315 1997 640 645
13. C.B. Granger, J.H. Alexander, and J.J.V. McMurray et al. Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992